Search research articles
Contact Us
Filters
Showing results (111-120 of 191) with videos related to
Page
of 20
Sort By:
BMC Biotechnology
|
July 24, 2021
Mapping the molecular basis for growth related phenotypes in industrial producer CHO cell lines using differential proteomic analysis
Laura Bryan, Michael Henry, Ronan M Kelly, et al.
Frontiers in Oncology
|
March 19, 2014
In vitro Development of Chemotherapy and Targeted Therapy Drug-Resistant Cancer Cell Lines: A Practical Guide with Case Studies
Martina McDermott, Alex J Eustace, Steven Busschots, et al.
Journal of Proteomics
|
January 18, 2011
2D-DIGE analysis of phospho-enriched fractions from dasatinib-treated melanoma cell lines
Alex J Eustace, Paul Dowling, Michael Henry, et al.
Biotechnology Journal
|
October 5, 2017
miR-CATCH Identifies Biologically Active miRNA Regulators of the Pro-Survival Gene XIAP, in Chinese Hamster Ovary Cells
Alan Griffith, Paul S Kelly, Sebastian Vencken, et al.
Proteomics
|
December 14, 2006
Proteomic screening of glucose-responsive and glucose non-responsive MIN-6 beta cells reveals differential expression of proteins involved in protein folding, secretion and oxidative stress
Paul Dowling, Lorraine O'Driscoll, Finbarr O'Sullivan, et al.
Cytotechnology
|
August 10, 2019
Zinc supplementation increases protein titer of recombinant CHO cells
Berta Capella Roca, Antonio Alarcón Miguez, Joanne Keenan, et al.
Electrophoresis
|
November 28, 2007
2-D difference gel electrophoresis of the lung squamous cell carcinoma versus normal sera demonstrates consistent alterations in the levels of ten specific proteins
Paul Dowling, Lorraine O'Driscoll, Paula Meleady, et al.
Journal of Biotechnology
|
December 1, 2010
Predicting cell-specific productivity from CHO gene expression
Colin Clarke, Padraig Doolan, Niall Barron, et al.
Experimental Cell Research
|
January 31, 2012
Characterization and response of newly developed high-grade glioma cultures to the tyrosine kinase inhibitors, erlotinib, gefitinib and imatinib
Paula Kinsella, Rachel Howley, Padraig Doolan, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
January 26, 2020
Characterisation and proteomic profiling of continuously exposed Cu-resistant variants of the Caco-2 cell line
Charles O'Doherty, Joanne Keenan, Michael Henry, et al.
Page
of 20
Search research articles
Search
Showing results (111-120 of 191) with videos related to
Sort By:
Page
of 20
BMC Biotechnology
|
July 24, 2021
Mapping the molecular basis for growth related phenotypes in industrial producer CHO cell lines using differential proteomic analysis
Laura Bryan, Michael Henry, Ronan M Kelly, et al.
Frontiers in Oncology
|
March 19, 2014
In vitro Development of Chemotherapy and Targeted Therapy Drug-Resistant Cancer Cell Lines: A Practical Guide with Case Studies
Martina McDermott, Alex J Eustace, Steven Busschots, et al.
Journal of Proteomics
|
January 18, 2011
2D-DIGE analysis of phospho-enriched fractions from dasatinib-treated melanoma cell lines
Alex J Eustace, Paul Dowling, Michael Henry, et al.
Biotechnology Journal
|
October 5, 2017
miR-CATCH Identifies Biologically Active miRNA Regulators of the Pro-Survival Gene XIAP, in Chinese Hamster Ovary Cells
Alan Griffith, Paul S Kelly, Sebastian Vencken, et al.
Proteomics
|
December 14, 2006
Proteomic screening of glucose-responsive and glucose non-responsive MIN-6 beta cells reveals differential expression of proteins involved in protein folding, secretion and oxidative stress
Paul Dowling, Lorraine O'Driscoll, Finbarr O'Sullivan, et al.
Cytotechnology
|
August 10, 2019
Zinc supplementation increases protein titer of recombinant CHO cells
Berta Capella Roca, Antonio Alarcón Miguez, Joanne Keenan, et al.
Electrophoresis
|
November 28, 2007
2-D difference gel electrophoresis of the lung squamous cell carcinoma versus normal sera demonstrates consistent alterations in the levels of ten specific proteins
Paul Dowling, Lorraine O'Driscoll, Paula Meleady, et al.
Journal of Biotechnology
|
December 1, 2010
Predicting cell-specific productivity from CHO gene expression
Colin Clarke, Padraig Doolan, Niall Barron, et al.
Experimental Cell Research
|
January 31, 2012
Characterization and response of newly developed high-grade glioma cultures to the tyrosine kinase inhibitors, erlotinib, gefitinib and imatinib
Paula Kinsella, Rachel Howley, Padraig Doolan, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA
|
January 26, 2020
Characterisation and proteomic profiling of continuously exposed Cu-resistant variants of the Caco-2 cell line
Charles O'Doherty, Joanne Keenan, Michael Henry, et al.
Page
of 20